Category: Therapeutic Area
Oceania Therapeutic Area
-
Asia Pacific Sex Toys Market Growth, Size, Trends Analysis- By Type, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
... research, ‘Asia Pacific Sex Toys Market Size- By Type, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the Asia Pacific Sex Toys Market is predicted to reach USD ... Read More
-
2024 Asia-Pacific In-Vitro Fertilization (Ivf) Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and Other Payloads), Target Antigens (HER-2 (ERBB2), CD79b, Trop-2, BCMA (TNFRSF17 / BCM), CD19, CD22, Tissue Factor, CD30, CEACAM5, Nectin 4 and Others) And Key Geographical Regions (North America (US, Canada), Europe (Germany, UK, France, Italy, Spain), and Asia-Pacific (China, Australia, Japan)): Industry Trends and Global Forecasts, Till 2035
... Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and ... Read More
-
2024 Asia-Pacific Cancer Diagnostics Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Asia-Pacific Cancer Supportive Care Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Asia-Pacific Breast Cancer Therapeutics Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
Cell and Gene Therapy Market Research Report Information by Therapy Type (Cell Therapy and Gene Therapy), Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... and Rest of the World) Industry Forecast till 2032 In 2023, the e-Visa market was estimated to be worth USD 933.4 million. With a compound annual growth rate (CAGR) of 11.1% from 2024 to 2032, ... Read More
-
Epilepsy Drugs Market, By Type of Epilepsy (Focal Epilepsy, Generalized Epilepsy, Reflex Epilepsy, and Others (Progressive Myoclonic Epilepsy, etc.)), By Drugs (1st Generation, 2nd Generation, and 3rd Generation), By Route of Administration (Oral, Injectable, and Others (Nasal, etc.)), By Age Group (Pediatric, Adults, and Geriatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Others (Nasal, etc.)), By Age Group (Pediatric, Adults, and Geriatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Epilepsy is ... Read More
-
Antibiotics and Antimycotics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Penicillins, Cephalosporins, Carbapenems, Macrolides, Aminoglycosides, Quinolones, Sulfonamides, Tetracyclines, Azoles, and Others), Indication (Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infections, Gastrointestinal Infections, and Others), Route of Administration (Oral, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drug Stores, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Indication (Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infections, Gastrointestinal Infections, and Others), Route of Administration (Oral, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drug Stores, and Online Pharmacies), and ... Read More
-
Asia Pacific Corporate Wellness Market, By Service Type (Health Risk Assessment, Nutrition & Weight Management, Smoking Cessation, Fitness Services, Stress Management, Health Screening & Assessment, Employee Assistance Programs (EAPs)); By Delivery Model (On-site Programs, Off-site Programs); By Category (Fitness & Nutrition Consultants, Psychological Therapists, Organizations/Employers, Fitness & Medical Institutions); By End User (Small Scale Organizations, Medium Scale Organizations, Large Scale Organizations); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of Asia Pacific), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... of increasing prevalence of lifestyle-related diseases, a growing emphasis on employee productivity, and expanding wellness program offerings in workplaces. BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Asia ... Read More
-
Clinical Decision Support System Market Research Report Information by Component (Software, Services, and Hardware) By Product (Integrated CDSS and Standalone CDSS), By Model (Knowledge-Based CDSS and Non-Knowledge-Based CDSS), By Delivery Mode (On-Premise CDSS and Cloud-Based CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced Clinical Decision Support Systems and Conventional Clinical Decision Support Systems), By Region (North America, Europe, Asia-Pacific, and Rest of the World) - Industry Forecast till 2032
... CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced ... Read More
-
Asia Pacific Noninvasive Fat Reduction Market Forecast to 2031 - Regional Analysis - by Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others) and End User (Hospitals, Dermatology & Cosmetic Clinics, and Other End Users)
... Pacific noninvasive fat reduction market was valued at US$ 415.08 million in 2023 and is projected to reach US$ 1,709.85 million by 2031; it is estimated to register a CAGR of 19.4% from 2023 to ... Read More
-
Asia Pacific Ophthalmology Devices Market Forecast to 2031 - Regional Analysis - by Product (Vision Care Products, Surgical Devices, and Diagnostics and Monitoring Devices), Application (Cataract, Glaucoma, Refractory Disorders, Vitreoretinal Disorders, and Other Applications), and End User (Hospital and Eye Clinics, Academic and Research Laboratories, and Other End Users)
... End User (Hospital and Eye Clinics, Academic and Research Laboratories, and Other End Users) The Asia Pacific ophthalmology devices market was valued at US$ 7,975.03 million in 2023 and is expected to reach US$ 15,872.71 ... Read More
-
Asia Pacific Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)
... Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others) The Asia Pacific ... Read More
-
Asia-pacific Dry Eye Disease Market Forecast (2024-2032)
... $1216.91 million in 2023, reaching a revenue of $1987.33 million by 2032. MARKET INSIGHTS Factors such as the increasing prevalence of dry eye disease and a rising demand for dry eye disease treatment products are ... Read More
-
Asia Pacific Assistive Robots Market: Market Size, Forecast, Insights, and Competitive Landscape
... assistive robot market provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the Asia Pacific assistive robot by categorising the market ... Read More
-
Paediatric Consumer Health in Australia
... products, the move has impacted chewable tablet formats. Announced by the TGA in May 2023, the new restrictions on acetaminophen include: reducing the maximum size of packs available for general sale (such as through supermarkets ... Read More
-
Digestive Remedies in Australia
... impacted consumer spending – in conjunction with higher interest rates and the rapid rise in the cost of living. Consumer Price Index (CPI) indicators reveal that spending on health, including pharmaceuticals, rose by 5.3% year-on-year ... Read More
-
Dermatologicals in Australia
... February 2024), skin conditions (including skin rashes, eczema and psoriasis) had a moderate to severe impact on everyday life for 49% of respondents in Australia, the highest rate on record since tracking began in 2019 ... Read More
-
NRT Smoking Cessation Aids in Australia
... Institute of Health and Welfare’s National Drug Strategy Household Survey 2022-2023, fewer than 10% of people in Australia over 14 years of age smoked daily, while the use of e-vapour products tripled between 2019 and ... Read More
-
Cough, Cold and Allergy (Hay Fever) Remedies in Australia
... September. While there was a concerning early start to the flu season in 2024, with unseasonably high rates of influenza and respiratory syncytial virus (RSV), as well as the nation’s first surge in whooping cough ... Read More
-
Organoids Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery and Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), Offering (Instruments, Consumables, and Services), Method (Micropatterned Plates, Ultralow Attachment Plates, Hanging Drop, Microdroplet/Emulsion, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery and Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), Offering (Instruments, Consumables, and Services), Method (Micropatterned Plates, ... Read More
-
NRT Smoking Cessation Aids in New Zealand
... year. While volume sales are being limited by falling smoking prevalence and the use of other methods to help quit smoking, value sales growth within the category are being strongly influenced by unit price growth, ... Read More
-
Digestive Remedies in New Zealand
... Zealand population, and this has also been exacerbated by the cost of living pressures faced by consumers. A high proportion of consumers do not eat the recommended number of servings of fruit and vegetables, and ... Read More
-
Paediatric Consumer Health in New Zealand
... growth for nappy (diaper) rash treatments and paediatric cough, cold and allergy remedies. Nevertheless, all categories are expected to see value growth, with overall paediatric consumer health set to see a similar retail current value ... Read More
Research Assistance
